Home  >  Products  >  RPL28 (ribosomal protein L28 ) Blocking Peptide (the N terminal of RPL28)(100ug)
RPL28 (ribosomal protein L28 ) Blocking Peptide (the N terminal of RPL28)(100ug)

RPL28 (ribosomal protein L28 ) Blocking Peptide (the N terminal of RPL28)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RPL28 Antibody (ARP65700_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65700
Size: 100ug
Weight: 19kDa
Gene: 6158
Format: Lyophilized powder
Target: Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L28E family of ribosomal proteins. It is located in the cytoplasm. Variable expression of this gene in colorectal cancers compared to adjacent normal tissues has been observed, although no correlation between the level of expression and the severity of the disease has been found. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome.
Alternative names: FLJ43307
See Full Product Listings >